|
Jul 17
|
MDGL Stock Soars 11% on New Patent Protecting Rezdiffra Dosing Rights
|
|
Jul 17
|
Recursion Pharmaceuticals Rises 6% in a Month: How to Play the Stock
|
|
Jul 17
|
Novartis Beats on Q2 Earnings and Sales, CFO Retires, Stock Down
|
|
Jul 16
|
Bayer Extends CEO’s Contract Through 2029
|
|
Jul 16
|
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
|
|
Jul 16
|
BAYRY Skyrockets 62.9% YTD: Should You Buy or Sell the Stock?
|
|
Jul 16
|
for Agriculture, Forestry, and Land Use Carbon Credits Market Analysis Report 2025 | Blockchain Tokenization and Retail Access, & Blended Finance Structures Fueling Opportunities
|
|
Jul 15
|
Connecticut wants to make generic GLP-1s. Will RFK Jr. lend a hand?
|
|
Jul 15
|
Will Key Drugs Maintain Momentum for Novartis in Q2 Earnings?
|
|
Jul 15
|
AstraZeneca Meets All Key Goals in Phase III Hypertension Study
|
|
Jul 15
|
Ultragenyx Pharmaceuticals Gets CRL for UX111 Gene Therapy for MPS IIIA
|
|
Jul 14
|
Bayer Gets FDA Nod for Label Expansion of Kerendia in Heart Failure
|
|
Jul 14
|
Myopic Macular Degeneration Market Analysis and Forecast Report 2025-2035 | Advancements in Anti-VEGF Therapies Driving Progress in Treatments
|
|
Jul 11
|
MRUS Stock Soars 30% in 3 Months After Phase II Cancer Study Success
|
|
Jul 11
|
Bayer Wins Hormone-Free Treatment Approval for Women in the UK
|
|
Jul 10
|
RARE, MREO Fall as Osteogenesis Study Likely to Continue Till Year End
|
|
Jul 10
|
Best Value Stocks to Buy for July 10th
|
|
Jul 10
|
New Strong Buy Stocks for July 10th
|
|
Jul 10
|
DKSH and Bayer Launch Strategic Partnership Across Multiple Markets in Southeast Asia
|
|
Jul 9
|
National Advertising Division Finds Certain Claims for OLLY’s Lovin’ Libido Supplement Supported; Recommends Sensation Claim be Discontinued
|